echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The tens of billions of ophthalmic drugs market Chengdu pharmaceutical companies' second-class new drugs strike

    The tens of billions of ophthalmic drugs market Chengdu pharmaceutical companies' second-class new drugs strike

    • Last Update: 2021-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 19, the CDE official website showed that Chengdu Kanghong Pharmaceutical's 2.
    4 category new drug KH737 eye drops was approved for clinical use, and its indication is to delay the progression of myopia in children
    .


    According to data from Mi Nei.


    KH737 eye drops is a 2.
    4-type new drug, and its indication is to delay the progression of myopia in children
    .


    Since the beginning of this year, Kanghong Pharmaceutical has obtained 4 clinical approvals, including the 2.


    According to data from Minai.


    Sales of terminal ophthalmic drugs in public medical institutions in China (unit: ten thousand yuan)

    Source: Mi Nei.


    Kanghong Pharmaceutical’s Conbercept ophthalmic injection was first approved for marketing in 2013.


    At present, Kanghong Pharmaceutical's Conbercept has grown into a large variety of 1 billion, and the market size is also continuing to rise.


    Data source: Minet database, CDE

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.